ArticleNature communications2026
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.
Ryan P Cantwell Chater et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it